Holen Sie sich die Stockscreener-App
8.71
2.11%
0.18
Handel nachbörslich:
8.75
0.04
+0.46%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NVAX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$8.53
Offen:
$8.55
24-Stunden-Volumen:
5.15M
Relative Volume:
0.83
Marktkapitalisierung:
$1.41B
Einnahmen:
$1.08B
Nettoeinkommen (Verlust:
$422.82M
KGV:
3.8202
EPS:
2.28
Netto-Cashflow:
$-637.33M
1W Leistung:
+9.15%
1M Leistung:
-8.51%
6M Leistung:
+10.11%
1J Leistung:
-30.43%
1-Tages-Spanne:
$8.52
$8.82
1-Wochen-Bereich:
$7.875
$8.82
52-Wochen-Spanne:
$5.01
$15.22
Novavax Inc Stock (NVAX) Company Profile
Firmenname
Novavax Inc
Sektor
Branche
Telefon
240-268-2000
Adresse
700 QUINCE ORCHARD ROAD, GAITHERSBURG, MD
Vergleichen Sie NVAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
8.71 | 1.39B | 1.08B | 422.82M | -637.33M | 2.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-20 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-06-17 | Eingeleitet | Citigroup | Sell |
| 2025-02-28 | Eingeleitet | BTIG Research | Buy |
| 2024-07-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Bestätigt | B. Riley Securities | Buy |
| 2022-12-30 | Bestätigt | H.C. Wainwright | Buy |
| 2022-12-02 | Eingeleitet | Jefferies | Hold |
| 2022-09-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2022-02-22 | Fortgesetzt | Jefferies | Buy |
| 2022-01-21 | Eingeleitet | Cowen | Outperform |
| 2021-05-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
| 2020-08-06 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Herabstufung | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-08 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Bestätigt | B. Riley FBR | Buy |
| 2020-06-29 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Bestätigt | B. Riley FBR | Buy |
| 2020-05-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-30 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-08-14 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-28 | Herabstufung | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-12-11 | Eingeleitet | Oppenheimer | Outperform |
| 2018-11-26 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Hochstufung | Seaport Global Securities | Neutral → Buy |
Alle ansehen
Novavax Inc Aktie (NVAX) Neueste Nachrichten
Novavax, Inc. $NVAX Stock Position Lessened by Goldman Sachs Group Inc. - MarketBeat
Novavax (NASDAQ:NVAX) Shares Up 5.1%Still a Buy? - MarketBeat
US Market Wrap: Can NTWOU generate free cash flow2025 Risk Factors & Real-Time Volume Spike Alerts - khodrobank.com
Buybacks Report: Will Novavax Inc stock go up in YEARJuly 2025 Gainers & Safe Entry Momentum Stock Tips - khodrobank.com
US vaccine advisers abandon broad recommendation for COVID shots - MarketScreener
Dow Update: Can Novavax Inc deliver consistent EPS growth2025 Technical Patterns & Detailed Earnings Play Strategies - khodrobank.com
Market Recap: Is Novavax Inc currently under institutional pressure2025 Technical Patterns & Daily Growth Stock Tips - khodrobank.com
Market Rankings: Is Novavax Inc a defensive stockJuly 2025 Recap & Smart Investment Allocation Insights - khodrobank.com
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'Dynavax Technologies (NASDAQ:DVAX), GSK (NYSE:GSK) - Benzinga
Weekly Recap: How correlated is Novavax Inc to the S P500Portfolio Performance Report & Intraday High Probability Alerts - khodrobank.com
Volume Recap: Does Babcock & Wilcox Enterprises Inc. meet Warren Buffett’s criteriaJuly 2025 Institutional & Stepwise Trade Signal Guides - khodrobank.com
Aug Action: Is Novavax Inc a play on infrastructure spendingCEO Change & Weekly High Conviction Trade Ideas - khodrobank.com
Novavax: Endlessly Frustrating, Endlessly FascinatingWarrants Rating Upgrade (NVAX) - Seeking Alpha
November 21st Options Now Available For Novavax (NVAX) - Nasdaq
Here's Why Novavax (NVAX) Fell More Than Broader Market - Yahoo Finance
West Coast states issue own vaccine guidance citing “politicization of science” under Trump - Seeking Alpha
Noteworthy Wednesday Option Activity: TGT, NVAX, DXCM - Nasdaq
MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response - Zacks Investment Research
Bayforest Capital Ltd Buys New Shares in Novavax, Inc. $NVAX - MarketBeat
Novavax Inc. Stock Climbs 5.9%, Outperforms Peers - 富途牛牛
Buybacks Report: Is Novavax Inc. exposed to currency risksJuly 2025 Volume & Free Expert Approved Momentum Trade Ideas - خودرو بانک
Market Recap: Can Novavax Inc sustain its profitabilityJuly 2025 Sector Moves & Long-Term Safe Investment Ideas - khodrobank.com
Aug Highlights: Is Novavax Inc stock technically oversoldQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - khodrobank.com
Aug Selloffs: Is Novavax Inc a play on infrastructure spendingQuarterly Portfolio Review & Expert Curated Trade Ideas - خودرو بانک
Profit Review: What is Novavax Incs TAM Total Addressable MarketJuly 2025 Summary & Weekly Top Gainers Alerts - خودرو بانک
Is Novavax at Risk After White House Considers COVID Shot Restrictions? - Yahoo Finance
Market Voices: Kenvue vs. RFK Jr., COVID shot safety, Lendbuzz IPO - Seeking Alpha
Northern Trust Corp Sells 48,282 Shares of Novavax, Inc. $NVAX - MarketBeat
Park West Asset Management LLC Invests $16.21 Million in Novavax, Inc. $NVAX - MarketBeat
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - sharewise.com
Novavax gets Japan nod for its COVID-19 vaccine, triggers Takeda payment - MSN
FDA Moves To Publicize Data On Pregnant Women's Covid Vaccine Side Effects - Benzinga
Market Trends: Is Novavax Inc. currently under institutional pressureQuarterly Risk Review & Safe Entry Point Identification - Lancaster City Council
What is Novavax Inc.’s TAM (Total Addressable Market)Market Rally & AI Optimized Trading Strategy Guides - beatles.ru
Will Novavax Inc. benefit from sector rotationMarket Sentiment Report & Daily Oversold Stock Bounce Ideas - beatles.ru
Novavax Falls on Report That FDA Wants New Covid Vaccine Trial - MSN
Finanzdaten der Novavax Inc-Aktie (NVAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Novavax Inc-Aktie (NVAX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Alton Gregg H | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
28,805 |
| King Rachel K. | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
25,190 |
| Rodgers Richard J | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
24,690 |
| MOTT DAVID M | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
60,890 |
| DOUGLAS RICHARD | Director |
Jun 12 '25 |
Option Exercise |
0.00 |
10,420 |
0 |
54,340 |
1.43%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):